Prevention
RSSArticles
-
Report: Pregnancy-Related Hypertensive Disorders Doubled in 12 Years
An estimated one in five births in the United States are affected by various adverse pregnancy outcomes.
-
Updated Aspirin Guidance from the U.S. Preventive Services Task Force
The authors of new recommendations advise avoiding initiating aspirin for primary prevention of cardiovascular disease in adults age 60 years or older, individualizing decisions based on characteristics and preferences for patients.
-
Sodium Restriction in Chronic, Stable Heart Failure Patients
A study of a low-sodium diet for chronic, stable heart failure patients after one year showed no difference in hard clinical outcomes, but the degree of sodium restriction was modest.
-
Panel Backs Away from Aspirin for Cardiovascular Disease Primary Prevention
Experts say patients age 60 years and older should not start taking the drug to prevent a first stroke or heart attack.
-
Gastrointestinal Bleeding on Anticoagulants: Predicting Colorectal Cancer in Afib Patients
A large Danish registry study showed that in atrial fibrillation patients on oral anticoagulants and who experience a lower gastrointestinal bleed (LGIB), the incidence of a subsequent diagnosis of colorectal cancer is significantly higher than in those without a LGIB.
-
Yoga for the Mind, Body, and Autonomic Nervous System
Randomization to yoga in addition to standard care to treat vasovagal syncope led to better outcomes than standard care alone, with reductions in syncopal and presyncopal events and improvement in quality of life scores at one year.
-
Stress as a Reversible Risk Factor in Atrial Fibrillation Management
Researchers scrutinize this recognized but poorly defined relationship.
-
Treatment Indication for Diabetes Drug Expanded to Include Heart Failure
FDA approves empagliflozin to help lower risk of hospitalization, death among heart failure patients.
-
More Research Needed on How Marijuana Affects Human Brain
American Heart Association conducts thorough literature review on the subject.
-
Screen Older Heart Failure Patients for Transthyretin Cardiac Amyloidosis
A screening study of heart failure patients ≥ age 60 years, left ventricular ejection fraction ≥ 40%, and left ventricle wall thickness ≥ 12 mm revealed 6.3% prevalence of transthyretin cardiac amyloidosis, a highly treatable disease.